PERRY DAVID P 4
4 · Better Therapeutics, Inc. · Filed Dec 20, 2023
Insider Transaction Report
Form 4
PERRY DAVID P
DirectorSee Remarks10% Owner
Transactions
- Award
Common Stock
2023-12-18+3,750→ 105,286 total
Holdings
- 3,636,364(indirect: By Trust)
Common Stock
- 21,336(indirect: By Trust)
Common Stock
- 293,150(indirect: By Spouse)
Common Stock
- 13,030,393(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]These shares are owned directly by the Perry Trust, a ten percent owner of the Issuer, and indirectly by David P. Perry ("Perry") as trustee of the Perry Trust. Perry is an officer, director and ten percent owner of the Issuer.
- [F2]These shares are owned directly by the Georgianna Maule-Ffinch 2015 Trust (the "Maule-Ffinch Trust"), a ten percent owner of the Issuer and indirectly by Perry's spouse, Georgianna Maule-Ffinch ("Maule-Ffinch"), as the sole trustee of the Maule-Ffinch Trust, for the benefit of Maule-Ffinch and her children. Perry disclaims beneficial ownership of these securities, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- [F3]These shares are owned direclty by Maule-Ffinch.
- [F4]These shares are owned directly by Doland R. Leo, Trustee of Pensus Limited Trust dated 06/12/2010 FBO Georgianna Maule-Ffinch (the "Pensus Limited Trust") for the benefit of Maule-Ffinch. Perry disclaims beneficial ownership of these securities, and the filing of this Form 4 is not an admission that Perry is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.